Schizophrenia

CLINICAL_TRIALS research · 2025-06-18

Clinical Trial Update: Investigation of the Effects of Virtual Reality Applications on Individuals Diagnosed With Schizophrenia [NA]

This entry reports a clinical trial evaluating the effects of virtual reality applications in individuals diagnosed with schizophrenia; the …

CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: Probing the Cannabinoid System in Individuals With a Family History of Psychosis [EARLY_Phase 1]

An early-phase 1 clinical trial conducted at Yale University to probe the cannabinoid system in individuals with a family history of psychos…

CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia [EARLY_Phase 1]

This entry notes an early Phase 1 trial at Peking University testing adjunctive thyroxine for avolition in schizophrenia, with the study not…

CLINICAL_TRIALS research · 2025-06-06

Clinical Trial Update: Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness [NA]

This clinical trial update notes that enrollment is ongoing by invitation for a study evaluating a mobile health post-discharge intervention…

CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation [NA]

This clinical trial update describes a study to restore spindle activity and thalamocortical efficiency in early-course schizophrenia using …

CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: App and Body Fat Scale in the Management of Overweight Patients [NA]

Trial status update for a study evaluating an app and body fat scale to manage overweight in patients with schizophrenia or bipolar disorder…

CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Toward a Computationally-Informed, Personalized Treatment for Hallucinations [EARLY_Phase 1]

An early-phase 1 study from Yale University is investigating a computationally-informed, personalized treatment for auditory hallucinations …

CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) [NA]

A clinical trial is actively recruiting to test whether neuromodulation can enhance brain connectivity in schizophrenia, sponsored by the Un…

CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: Efficacy of Hi-tACS for Schizophrenia Negative Symptoms [NA]

A clinical trial is recruiting to assess the efficacy of Hi-tACS (transcranial alternating current stimulation) for negative symptoms in sch…

CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia [Phase 1]

Phase 1 trial update describing a proposal to develop a rapid, cost-effective diagnostic test for schizophrenia; currently recruiting.

CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: Deep Brain Stimulation for Psychosis [NA]

A clinical trial update notes that recruitment is underway for deep brain stimulation as a treatment for psychosis in treatment-refractory s…

CLINICAL_TRIALS research · 2025-05-23

Clinical Trial Update: Ningbo Schizophrenia Cohort

The Ningbo Schizophrenia Cohort trial is listed as active but not recruiting participants.

CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination [NA]

This clinical trial entry describes an ongoing study evaluating whether transcranial direct current stimulation (tDCS)–mediated neuroplastic…

CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia [Phase 4]

Phase 4 clinical trial evaluating metabolic effects of adjunctive lumateperone in clozapine-treated patients with schizophrenia is currently…

CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 [Phase 1]

This is a Phase 1 MAD study to evaluate the safety, tolerability and pharmacokinetics of LY03017, with the trial sponsored by Luye Pharma Gr…

CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: HYEEG Discourse in Psychosis: A Neurobehavioural Study

This clinical trial update reports that the HYEEG Discourse in Psychosis: A Neurobehavioural Study is currently recruiting, sponsored by Dou…

CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) [NA]

A clinical trial is investigating neuromodulation to enhance brain connectivity in schizophrenia and is currently recruiting at UT Health Ho…

CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Magnetoencephalography in Psychosis Program

Clinical trial update about a magnetoencephalography study in psychosis and schizophrenia, sponsored by Douglas Mental Health University Ins…

CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling [NA]

A Stanford University-sponsored trial investigates ketogenic metabolic therapy (ketogenic dieting) for schizophrenia, bipolar disorder, and …

CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Auditory Localization in Schizophrenia [NA]

A clinical trial investigating auditory localization in schizophrenia, sponsored by Hôpital le Vinatier, with status not yet recruiting.